Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.
2.

Noninvasive analysis of skin iron and zinc levels in beta-thalassemia major and intermedia.

Gorodetsky R, Goldfarb A, Dagan I, Rachmilewitz EA.

J Lab Clin Med. 1985 Jan;105(1):44-51.

PMID:
3968464
3.
4.

Liver iron concentrations and urinary hepcidin in beta-thalassemia.

Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E.

Haematologica. 2007 May;92(5):583-8.

5.

The use of skin Fe levels as a surrogate marker for organ Fe levels, to monitor treatment in cases of iron overload.

Farquharson MJ, Bagshaw AP, Porter JB, Abeysinghe RD.

Phys Med Biol. 2000 May;45(5):1387-96.

PMID:
10843111
6.
7.

Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.

Mazza P, Giua R, De Marco S, Bonetti MG, Amurri B, Masi C, Lazzari G, Rizzo C, Cervellera M, Peluso A, et al.

Haematologica. 1995 Sep-Oct;80(5):398-404.

8.

Can iron fortification of flour cause damage to genetic susceptibles (idiopathic haemochromatosis and beta-thalassaemia major)?

Bothwell TH, Derman D, Bezwoda WR, Torrance JD, Charlton RW.

Hum Genet Suppl. 1978;(1):131-7. No abstract available.

PMID:
285024
9.

Binding of serum ferritin to concanavalin A in patients with iron overload and with chronic liver disease.

Chapman RW, Gorman A, Laulicht M, Hussain MA, Sherlock S, Hoffbrand AV.

J Clin Pathol. 1982 May;35(5):481-6.

10.

Iron chelation therapy in hereditary hemochromatosis and thalassemia intermedia: regulatory and non regulatory mechanisms of increased iron absorption.

Kontoghiorghes GJ, Spyrou A, Kolnagou A.

Hemoglobin. 2010 Jun;34(3):251-64. doi: 10.3109/03630269.2010.486335.

PMID:
20524815
11.

Optimisation of a polarised X-ray source for the in vivo measurement of platinum in head and neck tumours.

Ali PA, Bennet C, el-Sharkawi AM, Hancock DA.

Appl Radiat Isot. 1998 May-Jun;49(5-6):647-50.

PMID:
9569567
12.

Iron overload.

Iancu TC.

Mol Aspects Med. 1983;6(1):1-100. Review. No abstract available.

PMID:
6371428
13.

A feasibility study: in vivo x-ray fluorescence of iron using 109Cd.

Shukri A, Green S, Bradley DA.

Appl Radiat Isot. 1995 Jun-Jul;46(6-7):625. No abstract available.

PMID:
7633384
14.

The feasibility of measuring silver concentrations in vivo with x-ray fluorescence.

Graham SA, O'Meara JM.

Phys Med Biol. 2004 Aug 7;49(15):N259-66.

PMID:
15379029
15.

Does the haemosiderin iron core determine its potential for chelation and the development of iron-induced tissue damage?

Ward RJ, Legssyer R, Henry C, Crichton RR.

J Inorg Biochem. 2000 Apr;79(1-4):311-7. Review.

PMID:
10830882
16.

A noninvasive method for the evaluation of tissue iron deposition in beta-thalassemia major.

Zeimer R, Belkin M, Leitersdorff E, Rachmilewitz EA.

J Lab Clin Med. 1978 Jan;91(1):24-31.

PMID:
618988
18.

Can iron chelators influence the progression of atherosclerosis?

Marx JJ, Kartikasari AE, Georgiou NA.

Hemoglobin. 2008;32(1-2):123-34. doi: 10.1080/03630260701726871. Review.

PMID:
18274990
19.

Skin iron concentration: a simple, highly sensitive method for iron stores evaluation in thalassemia patients.

Youssry I, Mohsen NA, Shaker OG, El-Hennawy A, Fawzy R, Abu-Zeid NM, El-Beshlawy A.

Hemoglobin. 2007;31(3):357-65.

PMID:
17654073
20.

Use of portable X-ray fluorescence spectrometry for environmental quality assessment of peri-urban agriculture.

Weindorf DC, Zhu Y, Chakraborty S, Bakr N, Huang B.

Environ Monit Assess. 2012 Jan;184(1):217-27. doi: 10.1007/s10661-011-1961-6. Epub 2011 Mar 9.

PMID:
21384116

Supplemental Content

Support Center